Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

IGF-1R may play a role in female hair loss and could be a treatment target.

IGF-1 can help regrow hair and may be a promising treatment for hair loss.

Glucose metabolism is crucial for wound healing but can delay healing in chronic wounds due to increased stress and inflammation.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Women with PCOS often have sleep and mental health issues, especially if overweight or insulin resistant.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Metformin is less effective in men with early-onset hair loss.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

A pulse-based diet with exercise improved PCOS health more than another diet, but benefits didn't last long-term.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Eating barley for life may lead to healthier aging in mice.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Sex hormones affect liver fat and metabolic health differently in men and women.